RT Journal Article
SR Electronic
T1 Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003277
DO 10.1136/jitc-2021-003277
VO 9
IS 11
A1 Zou, Fangwen
A1 Faleck, David
A1 Thomas, Anusha
A1 Harris, Jessica
A1 Satish, Deepika
A1 Wang, Xuemei
A1 Charabaty, Aline
A1 Ernstoff, Marc S
A1 Glitza Oliva, Isabella C
A1 Hanauer, Stephen
A1 McQuade, Jennifer
A1 Obeid, Michel
A1 Shah, Amishi
A1 Richards, David M
A1 Sharon, Elad
A1 Wolchok, Jedd
A1 Thompson, John
A1 Wang, Yinghong
YR 2021
UL http://jitc.bmj.com/content/9/11/e003277.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.